Interventional and Structural Cardiologist. Dir. of Clinical and Outcomes Research,
@crfheart
. Director of Acad. Affairs,
@StFrancis_LI
. Die-hard Red Sox fan.
So, apparently, the statistics in the NEJM report on compassionate use remdesivir without a control group were wrong. 53 authors and not one knows how to conduct a Kaplan-Meier analysis??
@NoopurRajeMD
@JagSinghMD
Thank you very much for sharing this experience. It is enormously helpful to hear the medical professional’s perspective— both clinical and personal. I am so glad to hear Jag is doing better- praying for continued steady recovery.
Just today, I have had DMs from several cardiologists in states with plenty of COVID-19 cases where they say that their partners are refusing to stop doing elective procedures— justifying them as “urgent”. This is nuts.
@PrakritiGaba
Thank you for sharing this. All of us are with you in spirit and appreciate the tremendous effort despite the emotional strain. You are all heroes.
Although Italy had its worst day to date (6557 new cases, 793 deaths), in the "silver lining" department, it’s clear that COVID-19 cases and deaths are not growing exponentially in Italy anymore.
1/n- Congratulations to my brother, Josh Cohen, who successfully ran the Boston Marathon twice today (yes, you read that correctly). This morning he ran the official marathon, finishing in 3:25. And then he got in a van, went back to the starting line, and ran it again...
Italy COVID-19 Update (Day 5)
Sorry I'm late with this today- had to go grocery shopping for flour and kosher salt for my daughter (who is an amazing cook!). Growth rates continue to ↓ for both death and cases.
My first ever tweetorial! In the last 48 hours, there has been a lot of buzz in the lay press (WSJ, CNN) about a new observational study of hydroxychloroquine (HCQ) in COVID-19 ().
@CMichaelGibson
IMHO (and experience), burnout of physicians is almost always due to loss of control of one's professional life (whether real or perceived). Most physicians enjoy working hard, but they want to feel like they have some say over what they do and when they do it.
1/x Mini-Tweetorial on External Validity vs. Competing Risk.
Based on an ongoing discussion with
@drjohnm
,
@ATSandhu
,
@gcfmd
,
@mikejohansenmd
and others, I have put together this mini-tweetorial on how to think about external validity of trials vs. competing risks.
Nice summary of a landmark trial proving once and for all that PCi does relieve angina beyond the placebo effect. I agree with comments by
@rwyeh
that this study is not intended to inform practice so much as to answer a fundamental mechanistic and physiological question…
@AnastasiaSMihai
Hard to believe. For some reason, they decided to censor patients who died in an analysis that was looking at time to improvement. Unfortunately, this is what happens when publications are rushed.
Updated spreadsheet and graphs from Italy with data from 3/22/20 (5561 new cases, 651 new deaths)-- trends continue to be promising.
@CMichaelGibson
@ajaykirtane
Just finished a great day of Cardiology Grand Rounds at Stanford. It was fantastic to meet so many bright, inquisitive, and motivated
@StanCVFellows
. Thanks to
@SnehaShahJain
and
@wfearonmd
for inviting me and making me feel at home!
Italy COVID-19 Update (Day 10)
I took the weekend off to recharge, so today's charts and graphs include the last 3 days. Case incidence trends are definitely starting to improve. It may be a while for deaths to catch up, though. Stay safe, everyone!
@CMichaelGibson
@ajaykirtane
@ashishkjha
Very well explained. Reminiscent of the seminal studies of Medicare admission rates for New Haven vs. Boston by Wennberg and colleagues nearly 30 years ago. Threshold for hospital admission varies with capacity--> supply drives utilization (rather than just demand).
Let me add my voice to so many others in thanking the
#cardiotwitter
community for their teaching, passion, education, inspiration, and most importantly, friendship this past year. Happy Thanksgiving to all!
Italy COVID-19 Update (Day 13)
Trends continue to look favorable in Italy. Let's hope this is what things are starting to look like in the US in 2 weeks or so (since Italy is about 10 days ahead of us).
@CMichaelGibson
@ajaykirtane
Academic cardiologists: We jumped out of a stationary plane at 4 feet to make a fun point about how selection bias can affect even an RCT.
This guy: Hold my beer.
@rwyeh
@bnallamo
Congratulations to Suzanne Baron, MD MSc and the amazing health economics research group at
@MidAmericaHeart
who conducted this ground-breaking study!
#TAVR
is truly a revolutionary procedure.
Is
#TAVR
vs
#SAVR
more cost-effective in intermediate risk pts?
@djc795
@saintlukeskc
analysis of PARTNER 2 trial finds TAVR is projected to be economically dominant. Read more:
Congratulations to my long-time partner, colleague, and friend
@jspertus
for leading the QOL component of the ISCHEMIA trial and for showing the true value of coronary revascularization to our patients. Great culmination to a lifetime of work.
@Radial_ICG
I would argue that no IC is fully trained until the sh*t hits the fan in the middle of the night when no one else is around. And no volume of cases done with the attending watching from the control room is adequate training for that moment.
@FredWuMD
Make sure to remove all the double spaces after period before sacrificing those Oxford commas. Also, semicolons are only half a character; use them liberally. :)
Very useful information. Based on some anecdotes from the US and Italy, I wonder how much of this excess all-cause mortality is “unreported COVID” and how much is “collateral damage” among patients without COVID (e.g., waiting out a STEMI at home).
Still we miss the elephant in the room... all-cause deaths... just look at what happened in Northern Italy... this discrepancy between official COVID-19 deaths and true COVID-19 burden in mortality is the most likely explanation of the way too rosy situation in China
3/n- Here's a photo of him 4 years ago taking part in the World Marathon Challenge in which he ran 7 marathons in 7 days on 7 continents. If you can't tell, the photo is of the marathon he ran in Antartica.
Speaking of publishing, I am super-proud of my daughter,
@emily_ann_cohen
, who just published her first article as a professional freelance writer (is that a thing?) in
@hey_alma
.
#proudpapa
.
Outstanding work by
@rwyeh
and team from
@SmithBIDMC
to examine the benefit of
#Impella
in AMI/CS. If you are still confused after reading the paper, check out the editorial by
@manesh_patelMD
and yours truly for additional explanation and some key lessons (link below)
Investigators from
@SmithBIDMC
worked with
@US_FDA
investigators to apply state-of-the-science methods to examine the impact of Impella on outcomes in myocardial infarction patients with shock. The conclusions might surprise you.
@drjohnm
I have said this before— I agree with many others that the vast swath of level 2 guidelines and expert opinion are not worth the writing nor the reading. Tell us what we ought to do (level 1) and what we ought not to do (level 3), and that’s plenty.
@jedicath
@ZLevyMD
Hard to imagine that any single service could handle this crush. The Italian experience seemed to be that every service ended up having to take on these patients to make the workload tolerable.
Congratulations to
@SuzanneJBaron
, my amazing mentee, colleague, structural cardiologist, and friend on her presentation and simultaneous publication on 2 LBCTs at TCT this morning. Credit also to my incredible team at
@MidAmericaHeart
who make us all look good.
1/x- Observations from reviewing AHA Abstracts on Non-Coronary Cardiac Interventions-- a brief thread. Of 60 abstracts, 26 (43%) were either meta-analyses (n=9) or analyses of either the Nationwide Inpatient Sample (NIS, n=8) or National Readmissions Database (NRD, n=9)
Italy COVID-19 Update (Day 7)
Mortality trend is concerning, but as I mentioned yesterday, case trends (assuming consistent testing patterns) are more important than deaths in some ways, because deaths always lag. And rate of case growth shows continued slowing. (1/2)
I am so proud of my daughter,
@emily_ann_cohen
, who has led her college newspaper, the Bowdoin Orient, through this difficult year with integrity, class, and an indomitable spirit. These photos document both the process and joy of the accomplishment. Emily, you are amazing!
For those who want a balanced discussion of the WATCHMAN trials and why its approval by FDA might not be the craziest thing ever, read this nuanced thread by
@AlbertLinMD1
on the challenges that we all face in balancing evidence and innovation in the CV device space.
I hesitate to reply on Twitter where nuance goes to die, but, a few points on this thread by JM et al focusing in on Watchman as that's an area I feel comfortable with the data and history. Let's start with a few stipulations:
@DrQuinnCapers4
IMHO, a first year fellow in week 1 will learn far more from careful observation than from the stress of trying to perform skills they haven’t come close to mastering. There is a time to let them start the case. This isn’t it.
Congratulations to my colleague and mentee, Dr. Suzanne Baron, on having 2 LBCTs (yes, 2) selected for presentation at the upcoming TCT meeting in San Francisco! Please join us in the main arena on 9/29 to cheer her on. You won’t be disappointed!
Congratulations, Mayra-- 3 separate first author publications in a single issue of JACC Interventions is an amazing accomplishment! Thank you for your tremendous leadership in this field.
MITRAL Trial MAC Arm: Pts treated with TS ViMAC had 6.7% 30-day mortality, was lower than predicted by the STS score (mean 9.9%, median 6.2%). At 1 year, ViMAC was associated with improved symptoms & stable THV performance.
@MayoClinicCV
@JACCJournals
This was truly an inspiring talk of the true origins of TAVR. Don’t often see a standing ovation at SCAI. For those who haven’t heard Dr. Andersen speak, I hope you get the opportunity.
An honor to listen to Dr. Henning Andersen discuss the journey of
#TAVR
, from an idea he had 34 years ago with hardware store wires and a butcher-shop pig ❤️, to what it is today. Never give up on your vision!
#SCAI2023
Fascinating description of the introduction (via Twitter) of the Impella single-access technique and its rapid dissemination in interventional practice via social media. See poll below.
Congratulations to my friend and colleague,
@ziadalinyc
, on leading the ILLUMIEN-IV trial— a truly monumental trial and one that will be providing critical insights for the IC community for years to come.
@OPCILive
@DrAllenJ
@ESHLOF
@drjohnm
If the fellow had written more abstracts, they wouldn’t have had time to do that extra cath. And this complication might well have been avoided. Who says research doesn’t save lives? 😊
@manesh_patelMD
@DukeHealth
@camwolfe
My conclusion is that the "COVID-19 authorship rule" remains in effect-- more authors (56) than patients (53 after excluding 8 patients with incomplete data).
@drjohnm
@ajaykirtane
@rwyeh
Yup. Which is 149 more patients than were enrolled in the randomized trials that demonstrated that aortic valve replacement surgery is the “gold standard” for anything.
@drjohnm
The key to humor in a public forum is the ability to laugh at oneself. But that takes a fair amount of introspection and elf-confidence, both of which seem to be in relatively short supply.
@drjohnm
IMHO, metaanalysis of observational comparative effectiveness studies is one of the worst ideas in all of medical research. The process of metaanalysis completely obscures any understanding of the limitations of the individual studies, which are then amplified by pooling.
@pomyers
@BavariaMd
I'm sure everyone knows this, but this indirect "comparison" would be bad enough if it were risk-adjusted (which it isn't). Without risk adjustment, it's completely worthless.
Very proud of my daughter, Emily, and her co-editor for their dedication to keeping the oldest, continuously published college newspaper running strong despite the COVID epidemic. It was inspiring to watch her work into the early morning hours get the issue out.
#proudpapa
@saraceciliamtz
In general, guides with side holes provide false reassurance as the guide can still be obstructive with a normal appearing “tip pressure”. Better to control guide position with forward pressure on the wire and back it out after each injection.
I was going to tweet this study out, but I can’t do any better than
@mmamas1973
. Thanks for highlighting our work! Shout out to
@nmbutala
, fellow extraordinaire from
@MGHHeartHealth
and
@SmithBIDMC
who really led the study and will be first author on the paper.
@georgetolisjr
I think a lot of the problem is that academic programs see themselves as in the “research” biz rather than the “teaching” biz. Introspection would be a good place to start.
A recent publication suggests that the average starting salary for an IC is $611,000. I'm curious if this rings true. If you are a US-based IC and have started a new position in the last 5 years, what was your starting salary (excluding any bonuses or other perks)?
Congratulations to
@arnoldgehrke
for her LBCT presentation at
#TCT2023
– providing critical new insights into the QOL benefit of T-TEER. And kudos to
@SuzanneJBaron
for insightful comments. It has been a privilege to mentor both of these rockstars!!!
2/n- this time as part of a group running with race director, Dave McGillivray, to check the course for any stragglers. Yes, he's a little crazy, but he's still my baby brother.
#bostonmarathon2022
@CMichaelGibson
@drjohnm
Abstracts especially are a total crapshoot. My first AHA abstract as a fellow was accepted only as a poster (in a time when there were lots of oral abstract sessions). It was published as the lead article in NEJM the following week.
Italy COVID-19 Update (Day 17)
Data from Italy continue to look very encouraging-- especially with respect to cases. A couple of changes today: (1) Got rid of the spreadsheets; (2) Removed the first 5 days of data; (3) Adjusted y-axis scale on case graph.
@emily_fri
IMHO, burnout is directly proportional to loss of control. No amount of lectures to anyone is going to fix this until physicians regain a reasonable amount of autonomy over how they practice medicine.